Tofacitinib Treatment Is Associated With Modest and Reversible Increases in Serum Lipids in Patients With Ulcerative Colitis - Sands, BE; Taub, PR; Armuzzi, A (Clin Gastroenterol Hepatol, 2020)
et al.